Literature DB >> 12111623

Alkaline phosphatase in rheumatoid arthritis patients: possible contribution of bone-type ALP to the raised activities of ALP in rheumatoid arthritis patients.

Yuki Nanke1, S Kotake, H Akama, N Kamatani.   

Abstract

Raised serum alkaline phosphatase (ALP) activity in rheumatoid arthritis (RA) has been reported, although its aetiology is not clear. In this paper we investigate whether synovial tissue is a possible source of raised ALP activity in RA. The activities and isozymes of ALP were determined in sera and synovial fluids from 22 RA and seven osteoarthritis (OA) patients. The expression of both protein and ALP mRNA in synovial tissue was investigated immunohistochemically and by reverse transcription (RT) PCR. ALP activity was higher in serum and synovial fluid from RA patients than in those from OA patients. In addition, the ratio of levels of bone-type ALP to those of liver-type ALP was significantly higher in synovial fluid than in serum from RA patients. Bone-type ALP was positive around the perivascular area and the subepithelial cells in the synovial tissue from RA patients. In contrast, the synovial tissue from OA patients exhibited no staining. The mRNA of bone-type ALP was detected in RA synoviocytes. In conclusion, ALP levels were elevated in both serum and synovial fluid from RA patients. Bone-type ALP derived from the synovial tissue may contribute to the raised activities of ALP in RA patients.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12111623     DOI: 10.1007/s10067-002-8285-4

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  8 in total

1.  Improvement of bioavailability and anti-inflammatory potential of curcumin in combination with emu oil.

Authors:  Manish Kumar Jeengar; Shweta Shrivastava; Kala Nair; Sreenivasa Reddy Singareddy; Uday Kumar Putcha; M V N Kumar Talluri; V G M Naidu; Ramakrishna Sistla
Journal:  Inflammation       Date:  2014-12       Impact factor: 4.092

2.  Catabolic and anabolic periarticular bone changes in patients with rheumatoid arthritis: a computed tomography study on the role of age, disease duration and bone markers.

Authors:  Sophie Aschenberg; Stephanie Finzel; Sarah Schmidt; Sebastian Kraus; Klaus Engelke; Matthias Englbrecht; Jürgen Rech; Georg Schett
Journal:  Arthritis Res Ther       Date:  2013       Impact factor: 5.156

3.  Evaluation of protective efficacy of Spirulina platensis against collagen-induced arthritis in rats.

Authors:  Narendra Kumar; Surendra Singh; Nisha Patro; Ishan Patro
Journal:  Inflammopharmacology       Date:  2009-04-24       Impact factor: 4.473

Review 4.  TNF inhibitor therapy for rheumatoid arthritis.

Authors:  Xixi Ma; Shengqian Xu
Journal:  Biomed Rep       Date:  2012-11-29

5.  The culture microenvironment of juvenile idiopathic arthritis synovial fibroblasts is favorable for endochondral bone formation through BMP4 and repressed by chondrocytes.

Authors:  Megan M Simonds; Amanda R Schlefman; Suzanne M McCahan; Kathleen E Sullivan; Carlos D Rose; Anne Marie C Brescia
Journal:  Pediatr Rheumatol Online J       Date:  2021-05-12       Impact factor: 3.054

Review 6.  Gastrointestinal and hepatic manifestations of rheumatoid arthritis.

Authors:  Ellen C Ebert; Klaus D Hagspiel
Journal:  Dig Dis Sci       Date:  2011-01-04       Impact factor: 3.487

7.  miR‑204 inhibits the osteogenic differentiation of mesenchymal stem cells by targeting bone morphogenetic protein 2.

Authors:  Xiaofeng Jiang; Zuofu Zhang; Tao Peng; Guangda Wang; Qiang Xu; Guangrun Li
Journal:  Mol Med Rep       Date:  2019-11-05       Impact factor: 2.952

8.  Rebamipide, an Amino Acid Analog of 2(1H)-Quinolinone, Inhibits the Formation of Human Osteoclasts.

Authors:  Yuki Nanke; Tsuyoshi Kobashigawa; Toru Yago; Manabu Kawamoto; Hisashi Yamanaka; Shigeru Kotake
Journal:  Biomed Res Int       Date:  2016-11-14       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.